These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

378 related items for PubMed ID: 20061758

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The impact of human immunodeficiency virus on response to treatment and recurrence rate in patients treated for tuberculosis: two-year follow-up of a cohort in Lusaka, Zambia.
    Elliott AM, Halwiindi B, Hayes RJ, Luo N, Mwinga AG, Tembo G, Machiels L, Steenbergen G, Pobee JO, Nunn PP.
    J Trop Med Hyg; 1995 Feb; 98(1):9-21. PubMed ID: 7861484
    [Abstract] [Full Text] [Related]

  • 3. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
    Bwire R, Borgdorff MW, Sticht-Groh V, Rieder HL, Kawuma HJ, Bretzel G, Rüsch-Gerdes S.
    East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
    [Abstract] [Full Text] [Related]

  • 4. Long term follow up of HIV-infected patients with tuberculosis treated with 6-month intermittent short course chemotherapy.
    Swaminathan S, Deivanayagam CN, Rajasekaran S, Venkatesan P, Padmapriyadarsini C, Menon PA, Ponnuraja C, Dilip M.
    Natl Med J India; 2008 Jun; 21(1):3-8. PubMed ID: 18472696
    [Abstract] [Full Text] [Related]

  • 5. Clinical aspects and treatment outcome in HIV-associated pulmonary tuberculosis: an experience from a Thai referral centre.
    Hongthiamthong P, Riantawan P, Subhannachart P, Fuangtong P.
    J Med Assoc Thai; 1994 Oct; 77(10):520-5. PubMed ID: 7745373
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Paradoxical reactions during tuberculosis treatment in patients with and without HIV co-infection.
    Breen RA, Smith CJ, Bettinson H, Dart S, Bannister B, Johnson MA, Lipman MC.
    Thorax; 2004 Aug; 59(8):704-7. PubMed ID: 15282393
    [Abstract] [Full Text] [Related]

  • 10. Laboratory diagnosis of pulmonary tuberculosis in TB and HIV endemic settings and the contribution of real time PCR for M. tuberculosis in bronchoalveolar lavage fluid.
    Kibiki GS, Mulder B, van der Ven AJ, Sam N, Boeree MJ, van der Zanden A, Dolmans WM.
    Trop Med Int Health; 2007 Oct; 12(10):1210-7. PubMed ID: 17956503
    [Abstract] [Full Text] [Related]

  • 11. [Sputum smear conversion during intensive TB treatment phase according to HIV status, in hospitalised patients in Togo].
    Wateba MI, Diop SA, Salou M, Womitso K, Nichols S, Tidjani O.
    Med Mal Infect; 2011 Mar; 41(3):140-4. PubMed ID: 21282024
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The clinical burden of tuberculosis among human immunodeficiency virus-infected children in Western Kenya and the impact of combination antiretroviral treatment.
    Braitstein P, Nyandiko W, Vreeman R, Wools-Kaloustian K, Sang E, Musick B, Sidle J, Yiannoutsos C, Ayaya S, Carter EJ.
    Pediatr Infect Dis J; 2009 Jul; 28(7):626-32. PubMed ID: 19451858
    [Abstract] [Full Text] [Related]

  • 14. Highly active antiretroviral therapy (HAART) in adults with tuberculosis: current status.
    Kwara A, Flanigan TP, Carter EJ.
    Int J Tuberc Lung Dis; 2005 Mar; 9(3):248-57. PubMed ID: 15786886
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Mortality rates and recurrent rates of tuberculosis in patients with smear-negative pulmonary tuberculosis and tuberculous pleural effusion who have completed treatment.
    Banda H, Kang'ombe C, Harries AD, Nyangulu DS, Whitty CJ, Wirima JJ, Salaniponi FM, Maher D, Nunn P.
    Int J Tuberc Lung Dis; 2000 Oct; 4(10):968-74. PubMed ID: 11055765
    [Abstract] [Full Text] [Related]

  • 17. Sputum conversion at the end of intensive phase of Category-1 regimen in the treatment of pulmonary tuberculosis patients with diabetes mellitus or HIV infection: An analysis of risk factors.
    Banu Rekha VV, Balasubramanian R, Swaminathan S, Ramachandran R, Rahman F, Sundaram V, Thyagarajan K, Selvakumar N, Adhilakshmi AR, Iliayas S, Narayanan PR.
    Indian J Med Res; 2007 Nov; 126(5):452-8. PubMed ID: 18160750
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK, Kim JH, Kang H, Cho JS, Smego RA.
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [Abstract] [Full Text] [Related]

  • 20. Immune reconstitution inflammatory syndrome in HIV-infected patients with tuberculosis.
    Kiertiburanakul S.
    J Med Assoc Thai; 2010 Feb; 93(2):257-64. PubMed ID: 20302011
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.